| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Matsui Connie is a Director at HALOZYME THERAPEUTICS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 3 sells.
Estimated insider holdings value: $14.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2025 | STRO Sutro Biopharma, Inc. | Director | Buy | 50,000 | $0.80 | $39,950.00 | New | +36.3% | - | |
| Nov 5, 2021 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 32,000 | $40.38 | $1,292,112.91 | -7.8% | -15.7% | +14.4% | |
| Sep 11, 2020 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 32,000 | $27.06 | $865,792.00 | -12.9% | - | - |